blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3954691

EP3954691 - PROCESS FOR THE PREPARATION OF ENANTIOMERIC DERIVATIVES 4-PHENYL-6-METHYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDINE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.12.2022
Database last updated on 15.08.2024
FormerRequest for examination was made
Status updated on  19.08.2022
FormerThe application has been published
Status updated on  14.01.2022
Most recent event   Tooltip23.12.2022Application deemed to be withdrawnpublished on 25.01.2023  [2023/04]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2022/07]
Inventor(s)01 / CHEN, Junli
Shanghai, 201203 / CN
 [2022/07]
Representative(s)Belkacemi, Doria
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2022/07]
Application number, filing date21193914.516.02.2017
[2022/07]
Priority number, dateWO2016CN7413219.02.2016         Original published format: PCT/CN2016/074132
[2022/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3954691
Date:16.02.2022
Language:EN
[2022/07]
Search report(s)(Supplementary) European search report - dispatched on:EP19.01.2022
ClassificationIPC:C07D487/04
[2022/07]
CPC:
C07D487/04 (EP,IL,KR,US); A61K31/4985 (IL,KR); A61P31/22 (IL,KR)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/38]
Former [2022/07]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON ENANTIOMEREN DERIVATE 4-PHENYL-6-METHYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDINE[2022/07]
English:PROCESS FOR THE PREPARATION OF ENANTIOMERIC DERIVATIVES 4-PHENYL-6-METHYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDINE[2022/07]
French:PROCÉDÉ DE PRÉPARATION DE DERIVÉS ENANTIOMERIQUES DE 4-PHENYL-6-METHYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDINE[2022/07]
Examination procedure16.08.2022Examination requested  [2022/38]
16.08.2022Date on which the examining division has become responsible
17.08.2022Application deemed to be withdrawn, date of legal effect  [2023/04]
06.09.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2023/04]
Parent application(s)   TooltipEP17705612.4  / EP3416966
Fees paidRenewal fee
03.01.2022Renewal fee patent year 03
03.01.2022Renewal fee patent year 04
03.01.2022Renewal fee patent year 05
09.02.2022Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[ID]WO2015132276  (HOFFMANN LA ROCHE [CH], et al) [ID] 1-10 * Schemes 1 and 2 *;
 [X]WO2016016196  (HOFFMANN LA ROCHE [CH], et al) [X] 1-4,7-9* the whole document *
by applicantCN101041658
 WO2015132276
    - BASTIN R.J. et al., Organic Process Research & Development, (20000000), vol. 4, pages 427 - 435
    - ANSEL, H. et al., Pharmaceutical Dosage Forms and Drug Delivery Systems, (19950000), pages 1456 - 1457
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.